FREE SHIPPING ON ORDERS OVER $150

tobacco prevention and cessation impact factor Treatment of Use: JACC Health Promotion Series Life's Essential 8 - How

$27.55

Quantity
- +
Description

Variation was less in the use frequency of smokeless tobacco products across sociodemographic characteristics, which might, in part, be caused by the generally low daily use frequency of these products

tobacco prevention and cessation impact factor Treatment of Use: JACC Health Promotion Series Life's Essential 8 - How

J Am Med Inform Assoc 2008;15:2931 [DOI] [PMC free article] [PubMed] [Google Scholar] 13.Zeng QT, Goryachev S, Weiss S, et al

tobacco prevention and cessation impact factor Treatment of Use: JACC Health Promotion Series Life's Essential 8 - How

doi:10.1111/j.1468-0009.2009.00555.x

tobacco prevention and cessation impact factor Treatment of Use: JACC Health Promotion Series Life's Essential 8 - How

Phase IB combination study of copanlisib and nivolumab in advanced solid tumors and lymphomas

tobacco prevention and cessation impact factor Treatment of Use: JACC Health Promotion Series Life's Essential 8 - How

You may also like

recommand products